SCHEMBL4932690

SCHEMBL4932690

O=S(=O)(C=Cc1ccc(Cl)s1)N1CCNCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 11/20 0.43
MAPT P10636 2/20 0.42
USP2 O75604 1/20 0.39
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
NFKB1 P19838 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
MYLK Q15746 1/20 0.35
YAP1 P46937 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4932684 1.00 F10 (0.43) F10MAPTUSP2PTGS1PTGS2
SCHEMBL6794767 0.76 MAPT (0.55) F10MAPTUSP2ALDH1A1SMN1; SMN2
SCHEMBL6794763 0.76 MAPT (0.55) F10MAPTUSP2ALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL6194541 0.75 MAPT (0.54) F10MAPTUSP2ALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL6194545 0.75 MAPT (0.54) F10MAPTUSP2ALDH1A1SMN1; SMN2
SCHEMBL11478163 0.73 ALDH1A1 (0.50) MAPTALDH1A1SMN1; SMN2L3MBTL1MEN1
SCHEMBL11478168 0.73 ALDH1A1 (0.50) MAPTALDH1A1SMN1; SMN2L3MBTL1MEN1
SCHEMBL3165155 0.72 PTGS1 (0.45) F10PTGS1PTGS2MEN1KMT2A
SCHEMBL3165162 0.72 PTGS1 (0.45) F10PTGS1PTGS2MEN1KMT2A
SCHEMBL7076836 0.72 TSHR (0.65) MAPTALDH1A1SMN1; SMN2TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214495-A1 Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa ASTRAZENECA AB (SE) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214495-A1 Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa F10, F12, F11 F10 1/4885MAPT 4885/4885USP2 3643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.